BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia
Varettoni, Marzia, Matous, Jeffrey V
Published in Hematology/oncology clinics of North America (01.08.2023)
Published in Hematology/oncology clinics of North America (01.08.2023)
Get more information
Journal Article
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
Tam, Constantine S., Opat, Stephen, D'Sa, Shirley, Jurczak, Wojciech, Lee, Hui-Peng, Cull, Gavin, Owen, Roger G., Marlton, Paula, Wahlin, Björn E., Sanz, Ramón Garcia, McCarthy, Helen, Mulligan, Stephen, Tedeschi, Alessandra, Castillo, Jorge J., Czyz, Jaroslaw, Fernández de Larrea, Carlos, Belada, David, Libby, Edward, Matous, Jeffrey V., Motta, Marina, Siddiqi, Tanya, Tani, Monica, Trneny, Marek, Minnema, Monique C., Buske, Christian, Leblond, Veronique, Trotman, Judith, Chan, Wai Y., Schneider, Jingjing, Ro, Sunhee, Cohen, Aileen, Huang, Jane, Dimopoulos, Meletios
Published in Blood (29.10.2020)
Published in Blood (29.10.2020)
Get full text
Journal Article
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Mailankody, Sham, Matous, Jeffrey V, Chhabra, Saurabh, Liedtke, Michaela, Sidana, Surbhi, Oluwole, Olalekan O, Malik, Shahbaz, Nath, Rajneesh, Anwer, Faiz, Cruz, Jose Carlos, Htut, Myo, Karski, Erin E, Lovelace, Wade, Dillon, Myles, Butz, Eric, Ying, Wendy, Balakumaran, Arun, Kumar, Shaji K
Published in Nature medicine (01.02.2023)
Published in Nature medicine (01.02.2023)
Get full text
Journal Article
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia
Dimopoulos, Meletios A, Tedeschi, Alessandra, Trotman, Judith, García-Sanz, Ramón, Macdonald, David, Leblond, Veronique, Mahe, Beatrice, Herbaux, Charles, Tam, Constantine, Orsucci, Lorella, Palomba, M. Lia, Matous, Jeffrey V, Shustik, Chaim, Kastritis, Efstathios, Treon, Steven P, Li, Jianling, Salman, Zeena, Graef, Thorsten, Buske, Christian
Published in The New England journal of medicine (21.06.2018)
Published in The New England journal of medicine (21.06.2018)
Get full text
Journal Article
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Lonial, Sagar, Jacobus, Susanna, Fonseca, Rafael, Weiss, Matthias, Kumar, Shaji, Orlowski, Robert Z, Kaufman, Jonathan L, Yacoub, Abdulraheem M, Buadi, Francis K, O'Brien, Timothy, Matous, Jeffrey V, Anderson, Daniel M, Emmons, Robert V, Mahindra, Anuj, Wagner, Lynne I, Dhodapkar, Madhav V, Rajkumar, S Vincent
Published in Journal of clinical oncology (10.04.2020)
Published in Journal of clinical oncology (10.04.2020)
Get full text
Journal Article
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Dimopoulos, Meletios A, Dr Prof, Trotman, Judith, Prof, Tedeschi, Alessandra, MD, Matous, Jeffrey V, Prof, Macdonald, David, MD, Tam, Constantine, MBBS, Tournilhac, Olivier, Prof, Ma, Shuo, MD, Oriol, Albert, MD, Heffner, Leonard T, MD, Shustik, Chaim, Prof, García-Sanz, Ramón, Prof, Cornell, Robert F, MD, de Larrea, Carlos Fernández, MD, Castillo, Jorge J, MD, Granell, Miquel, MD, Kyrtsonis, Marie-Christine, MD, Leblond, Veronique, Prof, Symeonidis, Argiris, MD, Kastritis, Efstathios, MD, Singh, Priyanka, MS, Li, Jianling, MS, Graef, Thorsten, MD, Bilotti, Elizabeth, MSN, Treon, Steven, MD, Buske, Christian, Prof
Published in The lancet oncology (01.02.2017)
Published in The lancet oncology (01.02.2017)
Get full text
Journal Article
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study
Buske, Christian, Tedeschi, Alessandra, Trotman, Judith, García-Sanz, Ramón, MacDonald, David, Leblond, Veronique, Mahe, Beatrice, Herbaux, Charles, Matous, Jeffrey V, Tam, Constantine S, Heffner, Leonard T, Varettoni, Marzia, Palomba, M Lia, Shustik, Chaim, Kastritis, Efstathios, Treon, Steven P, Ping, Jerry, Hauns, Bernhard, Arango-Hisijara, Israel, Dimopoulos, Meletios A
Published in Journal of clinical oncology (01.01.2022)
Published in Journal of clinical oncology (01.01.2022)
Get full text
Journal Article
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
PRO, Barbara, ADVANI, Ranjana, YIN YANG, SIEVERS, Eric L, KENNEDY, Dana A, SHUSTOV, Andrei, BRICE, Pauline, BARTLETT, Nancy L, ROSENBLATT, Joseph D, ILLIDGE, Tim, MATOUS, Jeffrey, RAMCHANDREN, Radhakrishnan, FANALE, Michelle, CONNORS, Joseph M
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
LaCasce, Ann S., Bociek, R. Gregory, Sawas, Ahmed, Caimi, Paolo, Agura, Edward, Matous, Jeffrey, Ansell, Stephen M., Crosswell, Howland E., Islas-Ohlmayer, Miguel, Behler, Caroline, Cheung, Eric, Forero-Torres, Andres, Vose, Julie, O'Connor, Owen A., Josephson, Neil, Wang, Yinghui, Advani, Ranjana
Published in Blood (05.07.2018)
Published in Blood (05.07.2018)
Get full text
Journal Article
Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
Siegel, David S, Schiller, Gary J, Samaras, Christy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S, Talamo, Giampaolo, Acosta-Rivera, Mirelis, Bar, Michael, Quick, Donald, Anz, Bertrand, Fonseca, Gustavo, Reece, Donna, Pierceall, William E, Chung, Weiyuan, Zafar, Faiza, Agarwal, Amit, Bahlis, Nizar J
Published in Leukemia (01.12.2020)
Published in Leukemia (01.12.2020)
Get full text
Journal Article
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation
Gopal, Ajay K., Ramchandren, Radhakrishnan, O'Connor, Owen A., Berryman, Robert B., Advani, Ranjana H., Chen, Robert, Smith, Scott E., Cooper, Maureen, Rothe, Achim, Matous, Jeffrey V., Grove, Laurie E., Zain, Jasmine
Published in Blood (19.07.2012)
Published in Blood (19.07.2012)
Get full text
Journal Article
Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia
Flinn, Ian W., Cherry, Mohamad A., Maris, Michael B., Matous, Jeffrey V., Berdeja, Jesus G., Patel, Manish
Published in American journal of hematology (01.12.2019)
Published in American journal of hematology (01.12.2019)
Get full text
Journal Article
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma
Vij, Ravi, Wang, Michael, Kaufman, Jonathan L., Lonial, Sagar, Jakubowiak, Andrzej J., Stewart, A. Keith, Kukreti, Vishal, Jagannath, Sundar, McDonagh, Kevin T., Alsina, Melissa, Bahlis, Nizar J., Reu, Frederic J., Gabrail, Nashat Y., Belch, Andrew, Matous, Jeffrey V., Lee, Peter, Rosen, Peter, Sebag, Michael, Vesole, David H., Kunkel, Lori A., Wear, Sandra M., Wong, Alvin F., Orlowski, Robert Z., Siegel, David S.
Published in Blood (14.06.2012)
Published in Blood (14.06.2012)
Get full text
Journal Article
Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Mailankody, Sham, Matous, Jeffrey V, Chhabra, Saurabh, Liedtke, Michaela, Sidana, Surbhi, Oluwole, Olalekan O, Malik, Shahbaz, Nath, Rajneesh, Anwer, Faiz, Cruz, Jose Carlos, Htut, Myo, Karski, Erin E, Lovelace, Wade, Dillon, Myles, Butz, Eric, Ying, Wendy, Balakumaran, Arun, Kumar, Shaji K
Published in Nature medicine (01.12.2023)
Published in Nature medicine (01.12.2023)
Get full text
Journal Article
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia
Buske, Christian, Tedeschi, Alessandra, Trotman, Judith, García-Sanz, Ramón, MacDonald, David, Leblond, Veronique, Mahe, Beatrice, Herbaux, Charles, Matous, Jeffrey V, Tam, Constantine S, Heffner, Leonard T, Varettoni, Marzia, Palomba, M Lia, Shustik, Chaim, Kastritis, Efstathios, Treon, Steven P, Ping, Jerry, Hauns, Bernhard, Arango-Hisijara, Israel, Dimopoulos, Meletios A
Published in Future oncology (London, England) (01.02.2023)
Published in Future oncology (London, England) (01.02.2023)
Get full text
Journal Article
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
Bartlett, Nancy L, Chen, Robert, Fanale, Michelle A, Brice, Pauline, Gopal, Ajay, Smith, Scott E, Advani, Ranjana, Matous, Jeffrey V, Ramchandren, Radhakrishnan, Rosenblatt, Joseph D, Huebner, Dirk, Levine, Pamela, Grove, Laurie, Forero-Torres, Andres
Published in Journal of hematology and oncology (19.03.2014)
Published in Journal of hematology and oncology (19.03.2014)
Get full text
Journal Article
Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180
TREON, Steven P, LOAKIMIDIS, Leukothea, KEOGH, George P, MYERS, Thomas J, BORAL, Andy, BIRNER, Ann, ESSELTINE, Dixie L, GHOBRIAL, Irene M, SOUMERAI, Jacob D, PATTERSON, Christopher J. J, SHEEHY, Patricia, NELSON, Marybeth, WILLEN, Michael, MATOUS, Jeffrey, MATTERN, John, DIENER, Jakow G
Published in Journal of clinical oncology (10.08.2009)
Published in Journal of clinical oncology (10.08.2009)
Get full text
Journal Article
Brentuximab vedotin, an antibody–drug conjugate, in patients with CD30‐positive haematologic malignancies and hepatic or renal impairment
Zhao, Baiteng, Chen, Robert, O'Connor, Owen A., Gopal, Ajay K., Ramchandren, Radhakrishnan, Goy, Andre, Matous, Jeffrey V., Fasanmade, Adedigbo A., Manley, Thomas J., Han, Tae H.
Published in British journal of clinical pharmacology (01.09.2016)
Published in British journal of clinical pharmacology (01.09.2016)
Get full text
Journal Article
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma
Delimpasi, Sosana, Dimopoulos, Meletios A., Straub, Jan, Symeonidis, Argiris, Pour, Luděk, Hájek, Roman, Touzeau, Cyrille, Bhanderi, Viralkumar K., Berdeja, Jesus G., Pavlíček, Petr, Matous, Jeffrey V., Robak, Pawel J., Suryanarayan, Kaveri, Miller, Alison, Villarreal, Miguel, Cherepanov, Dasha, Srimani, Jaydeep K., Yao, Huilan, Labotka, Richard, Orlowski, Robert Z.
Published in American journal of hematology (01.09.2024)
Published in American journal of hematology (01.09.2024)
Get full text
Journal Article
Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM Trial
Trotman, Judith, Buske, Christian, Tedeschi, Alessandra, Matous, Jeffrey V., MacDonald, David, Tam, Constantine S., Tournilhac, Olivier, Ma, Shuo, Treon, Steven P., Oriol, Albert, Ping, Jerry, Briso, Eva M., Arango-Hisijara, Israel, Dimopoulos, Meletios A.
Published in Clinical cancer research (01.11.2021)
Published in Clinical cancer research (01.11.2021)
Get full text
Journal Article